Salarius Pharmaceuticals's total assets for Q1 2024 were $4.88M, a decrease of -25.85% from the previous quarter. SLRX total liabilities were $1.23M for the fiscal quarter, a -5.01% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.